×
About 26,485 results

Physicians React: On Access to Quality, Affordable Healthcare 
https://www.medscape.com/viewarticle/984985

Dec 5th, 2022 - Healthcare access is not an issue only for patients. In a recent Medscape report, more than a third of doctors surveyed said access to quality, affordable healthcare had affected them or their families. "Access affects even the highest earnings," noted one survey respondent, an ob/gyn. And about half of respondents in the Physicians Rate Healthcare Access Report: Ongoing Problem for Patients ch...

Pfizer to Invest More Than $2.5 Billion to Expand European Manufacturing
https://www.medscape.com/viewarticle/984908

Dec 5th, 2022 - NEW YORK (Reuters) - Pfizer Inc is investing more than $2.5 billion at its drug making plants in Belgium and Ireland, gearing up to launch new products it hopes can replace lost revenue as patents expire and COVID-19 vaccine sales decline. The drugmaker said on Friday it plans to spend more than 1.2 billion euros ($1.26 billion) to expand its Puurs, Belgium, manufacturing site, matching the inv...

TikTok Creates Ozempic Shortage; New MS Framework Proposed; and AI May Cut Bias in Drug Trials
https://www.medscape.com/viewarticle/984741

Dec 1st, 2022 - TikTok Creates Ozempic Shortage TikTok is fueling demand for Ozempic, creating shortages of the diabetes drug now used for weight loss. Videos on TikTok hashtagged #ozempic have amassed more than 275 million views, and #ozempicweightloss has more than 110 million. The trend follows social media posts by celebrities such as Kim Kardashian and Elon Musk touting their own use of the drug or weight...

Male Infertility: A Threat to the Human Race?
https://www.medscape.com/viewarticle/984842

Dec 1st, 2022 - A large-scale meta-analysis has confirmed that there has been a drop in average sperm counts in men — a situation affecting countries around the world and that shows no sign of slowing down. Jean-Marc Ayoubi, MD, head of the Department of Gynecology and Obstetrics and Reproductive Medicine at Foch Hospital in Suresnes, France, gives us the inside story. In 1973, the average sperm count in men w...

Shorter Fever Prevention Duration Effective After Cardiac Arrest
https://www.medscape.com/viewarticle/984852

Dec 1st, 2022 - Outcomes were similar for comatose patients who received 36 vs 72 hours of device-based temperature control after out-of-hospital cardiac arrest, a randomized trial shows. "Since 2005, active fever prevention in comatose patients has been advocated by the guidelines for 72 hours after an out-of-hospital cardiac arrest," Christian Hassager, MD, of the University of Copenhagen, Copenhagen, Denmar...

How Can Clinicians Distinguish Food Allergy and GERD in Young Kids?
https://www.medscape.com/viewarticle/984898

Dec 1st, 2022 - The debate about a possible link between food allergy (FA) and pediatric gastroesophageal reflux disease (GERD) continues, and more, better-designed research is needed, a position paper by the European Academy of Allergy and Clinical Immunology reports. The report offers consensus-based recommendations and a graphical decision pathway to guide providers through assessing and treating food aller...

'Call to Action' for DPYD Testing Before Fluorouracil Chemo
https://www.medscape.com/viewarticle/984799

Dec 1st, 2022 - The debate over whether or not to test for DPYD gene variants before administering fluoropyrimidine (FP) chemotherapy has erupted again among experts in the United States, where such testing is not recommended at present, unlike in Europe. Testing for DPYD variants and subsequent dose adjustment should be offered to US patients who are due to receive fluoropyrimidine chemotherapy, says Daniel L...

COVID Hit HIV Detection in Europe, Threatens Eradication Progress
https://www.medscape.com/viewarticle/984817

Dec 1st, 2022 - LONDON (Reuters) - The number of people in Europe with undiagnosed HIV has risen as testing rates fell during the COVID-19 pandemic, threatening a global goal of ending the disease by 2030, a report said. The joint World Health Organization (WHO) and European Centre for Disease Prevention and Control (ECDC) report said that in 2021 a quarter fewer HIV diagnoses were recorded compared to pre-pan...

European Women's Work-Life Balance Worsened Since COVID Outbreak: Study
https://www.medscape.com/viewarticle/984818

Dec 1st, 2022 - (Reuters) - European women's work-life balance has worsened since the start of the COVID-19 pandemic in 2020, a European Institute for Gender Equality (EIGE) report shows. The EIGE's Gender Equality Index 2022, which has a thematic focus on care, showed that the pandemic has increased informal and unpaid care at home, particularly pressuring women. Women in the survey were more likely to face i...

New Genetic Variant Linked to Maturity-Onset Diabetes of the Young
https://www.medscape.com/viewarticle/984757

Nov 30th, 2022 - A newly discovered genetic variant that is associated with type 2 diabetes (T2D) is responsible for almost 7% of all diabetes cases in Greenland, according to a whole-genome sequencing analysis of 448 Greenlandic Inuit individuals. The variant, identified as c.1108G>T, "has the largest population impact of any previously reported variant" within the HNF1A gene – a gene that can cause maturity-o...

Rituximab Raises Remission Rate in GPA Vasculitis
https://www.medscape.com/viewarticle/984760

Nov 30th, 2022 - More patients with granulomatosis with polyangiitis (GPA) were in remission at 6 months if they had received rituximab (Rituxan) rather than cyclophosphamide (Cytoxan) as induction therapy, according to a target trial emulation performed by the French Vasculitis Study Group (FVSG). Remission, which was defined as a score of zero on the validated Birmingham Vasculitis Activity Score (BVAS) and u...

French COVID Cases on the Rise Again: Government Spokesman
https://www.medscape.com/viewarticle/984705

Nov 30th, 2022 - PARIS (Reuters) - New COVID-19 infections are on the rise again in recent days, French government spokesman told journalists on Tuesday. "The COVID epidemic seems to be picking up again", Olivier Veran said, adding there was a 40% rise in new cases since last week. (Reporting by Tassilo Hummel)

Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi
https://www.reuters.com/article/horizon-therapeu-ma/horizon-therapeutics-fields-buyout-interest-from-amgen-jj-and-sanofi-idUSL4N32P3O4

Nov 29th, 2022 - Nov 29 (Reuters) - Horizon Therapeutics Plc said on Tuesday it was engaged in highly preliminary discussions with Amgen Inc, Johnson & Johnson unit Janssen Global Services and Sanofi for potential takeover offers. (Reporting by Leroy Leo in Bengaluru; Editing by Sriraj Kalluvila)

Half of Britain's free range Christmas turkeys lost to bird flu crisis
https://www.reuters.com/article/britain-turkeys/half-of-britains-free-range-christmas-turkeys-lost-to-bird-flu-crisis-idUSL8N32P5A6

Nov 29th, 2022 - LONDON, Nov 29 (Reuters) - About half of the free range turkeys and geese reared for Christmas in Britain have either died or been culled due to the country’s largest-ever outbreak of avian flu, an industry head said on Tuesday. Richard Griffiths, Chief Executive of the British Poultry Council, told lawmakers that British farmers usually produce 1.2 to 1.3 million free range birds for the festi...

UK regulator says reactions in eye from Sanofi drug must be quickly reviewed
https://www.reuters.com/article/sanofi-dupixent-britain/uk-regulator-says-reactions-in-eye-from-sanofi-drug-must-be-quickly-reviewed-idUSL4N32P33W

Nov 29th, 2022 - Nov 29 (Reuters) - Britain’s medicines regulator said on Tuesday that any new or worsening reactions in patients’ eyes arising from use of Sanofi’s best-selling drug Dupixent should be promptly reviewed by healthcare professionals. The UK’s Medicines and Healthcare products Regulatory Agency said most ocular reactions seen with the drug are mild and can be managed. (Reporting by Pushkala Aripak...

Polish judge critical of government to return to work after 2 years
https://www.reuters.com/article/poland-eu-judiciary-tuleya/polish-judge-critical-of-government-to-return-to-work-after-2-years-idUSL8N32P2G7

Nov 29th, 2022 - WARSAW, Nov 29 (Reuters) - A Polish judge fiercely critical of the nationalist government’s judicial reforms was reinstated in his job on Tuesday by a new disciplinary body after being suspended for two years. Changes to the Polish judiciary have led Brussels to withhold some European Union funds for Poland. It says Warsaw must fulfil milestones related to judicial independence, reinstate unlaw...

IMF chief urges more targeted COVID approach in China -AP interview
https://www.reuters.com/article/health-coronavirus-china-imf/imf-chief-urges-more-targeted-covid-approach-in-china-ap-interview-idUSW1N32A008

Nov 29th, 2022 - WASHINGTON, Nov 29 (Reuters) - IMF Managing Director Kristalina Georgieva on Tuesday urged Beijing to back away from stringent lockdowns to manage ongoing COVID-19 cases and instead move toward more targeted actions, citing the impact on China’s people and economy in an interview with the Associated Press. Georgieva called on Beijing to undergo a “recalibration” of its so-called “zero COVID” ap...

India's Gland Pharma to buy France's Cenexi for $124 mln
https://www.reuters.com/article/cenexi-ma-gland-pharma/indias-gland-pharma-to-buy-frances-cenexi-for-124-mln-idUSL4N32P2PO

Nov 29th, 2022 - BENGALURU, Nov 29 (Reuters) - Indian generic injectables maker Gland Pharma Ltd said on Tuesday it will buy French pharmaceutical firm Cenexi for 120 million euros ($124.3 million) as it looks to expand its presence in European markets. ($1 = 0.9651 euros) (Reporting by Anuran Sadhu in Bengaluru; Editing by Shounak Dasgupta)

FOCUS-Rare success for Alzheimer's research unlocks hope for future therapies
https://www.reuters.com/article/health-alzheimers-targets/focus-rare-success-for-alzheimers-research-unlocks-hope-for-future-therapies-idUSL1N32O2E3

Nov 29th, 2022 - CHICAGO, Nov 29 (Reuters) - The first big breakthrough in 30 years of Alzheimer’s research is providing momentum for clinical trials of “cocktail” treatments targeting the two hallmark proteins associated with the mind-robbing disease, according to interviews with researchers and pharmaceutical executives. Drugmakers Eisai Co Ltd and Biogen reported in September that their therapy lecanemab cou...

Pregnancy Not a Barrier to Interventional Cardiology Career
https://www.medscape.com/viewarticle/984724

Nov 29th, 2022 - A new collaborative position paper on radiation exposure during pregnancy states that pregnant women can safely work in an ionizing radiation environment if exposure to the fetus does not exceed certain dose thresholds. The position paper aims to "avoid discouraging" women from pursuing careers in interventional cardiology/electrophysiology (IC/EP) and to "dismantle" a barrier that says, "activ...